Determination of Doxorubicin and Doxorubicinol in Plasma of Cancer Patients by High-Performance Liquid Chromatography

This publication has 18 references indexed in Scilit:

• The effects of cyclosporine on the pharmacokinetics of doxorubicin in patients with small cell lung cancer
  Cancer, 1994
• Anthracycline Antibiotics in Cancer Therapy
  Drugs, 1994
• Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia.
  Journal of Clinical Oncology, 1993
• Modulation of multidrug-resistant multiple myeloma by cyclosporin
  The Lancet, 1992
• Clinical Pharmacokinetics of Doxorubicin
  Clinical Pharmacokinetics, 1988
• Loop-Column Extraction and Liquid Chromatographic Analysis of Doxorubicin and Three Metabolites in Plasma
  Therapeutic Drug Monitoring, 1985
• Disposition of 14C-labelled 4?-epidoxorubicin and doxorubicin in the rat
  Cancer Chemotherapy and Pharmacology, 1984
• Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell Lines
  Science, 1983
• Fluorescence assays and pharmacokinetic studies of 4′-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumors
  Cancer Chemotherapy and Pharmacology, 1981
• Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesius
  Biotechnology & Bioengineering, 1969